At present, it is clinically applied immunotherapy target ICI with programmed death 1 (PD-1) 103 and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) 104, 105, expressed in T cell surface negative direction The T cell function is regulated so that the tumor tissue is immunized. Here, CTLA4 is linked to neoplasm.